Navigation Links
Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
Date:11/7/2012

cerMore than one million people worldwide are diagnosed with breast cancer globally every year. (1)  The chance of developing invasive breast cancer at some time in a woman's life is a little less than one in eight (12%).  There are approximately 200,000 new cases of breast cancer in the United States and 430,000 in Europe each year. (2)  Metastatic breast cancer refers to cancer that has spread from the breast to distant sites in the body. 

Anthracyclines and taxanes (AT) are the most active and widely used chemotherapeutic agents for breast cancer, but the increased use of these agents at an early stage of disease often renders tumors resistant to these drugs by the time the disease recurs, thereby reducing the number of treatment options for metastatic disease. Drugs used to treat patients who progress following AT treatment can have response rates of 20-30%; however, resistance develops rapidly and new agents with different mechanisms of action, such as topoisomerase I inhibitors, are needed that have the potential to overcome the problem of drug resistance to prior therapies. (3)  There are currently no FDA-approved topoisomerase I inhibitors to treat breast cancer.

About NektarNektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other therapeutic areas. In the area of pain, Nektar has an exclusive worldwide license agreement with AstraZeneca for naloxegol (NKTR-118), an investigational drug candidate, which is being evaluated in Phase 3 clinical studies as a once-daily, oral tablet for the treatment of opioid-induced constipation.  This agreement also includes NKTR-119, an earlier stage development program that is a co-formulation of naloxegol and an opioid.  NKTR-181, a novel mu-opioid analgesic can
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2012 On Tuesday, November 13, 2012, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
3. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2012
4. Nektar Announces Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) in Patients with Bevacizumab (Avastin)-resistant High-Grade Glioma
5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
6. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
7. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
10. Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
11. Blue Belt Technologies Announces First United Kingdom-Based NavioPFS Unicondylar Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014  CorMedix Inc. (NYSE MKT: CRMD), ... therapeutic products for the prevention and treatment of ... announce that TUV-SUD and The Medicinal Evaluation Board ... has granted its request for a label expansion ... initially approved in July 2013 for use in ...
(Date:9/22/2014)... PLEASANTON, Calif. , Sept. 22, 2014 ... leader in device-based mechanical circulatory support therapies to save, ... D. Keith Grossman has been appointed President and ... F. Burbach , who has stepped down from his ... advisor to the company through the first quarter of ...
(Date:9/22/2014)... Sept. 22, 2014 Auxilium Pharmaceuticals, Inc. ... company, today announced that its Board of Directors ... conditional proposal from Endo International plc ("Endo") and, ... advisors, has unanimously determined it is not a ... merger agreement with QLT Inc. ("QLT") and has ...
Breaking Medicine Technology:Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5Auxilium Provides Transaction Update 2Auxilium Provides Transaction Update 3Auxilium Provides Transaction Update 4Auxilium Provides Transaction Update 5Auxilium Provides Transaction Update 6
... Based on its recent analysis of the ... Hybridyne Technologies, Inc. with the 2010 North American ... the Year. (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ... ProxiScan™, recently approved by the FDA, is ...
... Upstate New York Laboratory Robotics Interest Group (LRIG) ... Society of Mechanical Engineers (ASME) will be hosting ... 27, 2010 entitled "Unconventional High-Throughput Applications," featuring Pankaj ... Seth Cohen, Ph.D., Senior Director Microfluidics Applications, Caliper ...
Cached Medicine Technology:Frost & Sullivan Award Highlights Hybridyne Technologies' Outstanding Technology Innovation 2Frost & Sullivan Award Highlights Hybridyne Technologies' Outstanding Technology Innovation 3Frost & Sullivan Award Highlights Hybridyne Technologies' Outstanding Technology Innovation 4Upstate New York Laboratory Robotics Interest Group (LRIG) to Host Free Symposium and Exhibition 2
(Date:9/22/2014)... Malaysia today became a founding partner in the Global ... to promoting young talent in science, technology, engineering and ... New York Academy of Sciences (NYAS), Malaysian Prime Minister ... Monday Sept. 22. , With the goal of developing ... countries by 2020, the initiative will create a host ...
(Date:9/22/2014)... September 22, 2014 This Flash Report ... stakeholder management needs for the Prostate Cancer market. , ... on stakeholder strategies for any launching Prostate Cancer product:, ... differentiation within an increasingly crowded market , ... impact of identifying community-based thought leaders and stakeholders ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 The R&D ... the recent years. The statistically important data received from ... of cancer vaccines. The primary challenge to the development ... about the exact mechanism of how a human’s immune ... various results in different individuals owing to known factors ...
(Date:9/22/2014)... Sept. 22, 2014 (HealthDay News) -- Two new prescription ... (FDA) may provide some relief for people with migraine ... a new study. One device -- the Cefaly ... device -- the Cerena -- is meant to be ... news release. "Patients have been looking for alternative ...
(Date:9/22/2014)... Nanuet, NY (PRWEB) September 22, 2014 ... Blindness, Rockland Chrysler Jeep Dodge Ram is launching an ... Blind Egg Challenge (#blindeggchallenge or #ffbBEC) aims to raise ... Egg Challenge involves throwing an egg in the air ... at least three others and if a nominee does ...
Breaking Medicine News(10 mins):Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 3Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 4Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Blind Egg Challenge Raises Awareness for Foundation Fighting Blindness 2
... ... in pursing careers in medical transcription and medical coding and billing. , ... Provo, Utah (PRWEB) June 5, ... Community College in Roxboro, N.C. to offer training to individuals interested in pursing careers ...
... announced today its decision to expand its use of ... sanitizer, to all its service centers nationwide after testing ... the first major healthcare laundry processor to implement the ... wash process will elevate the standard of cleanliness in ...
... Univision, People en Espanol, Ser Padres and impreMedia health expert Aliza ... Doctora Aliza (TM), announced the launch of her Spanish-language health hub ... http://www.newscom.com/cgi-bin/prnh/20090604/SF28145 ) , , " VidaySalud.com ... wellness tools in Spanish on the web. It includes ...
... Gift Cards, Inspiring Star Cards Make Giving Easy , ... Maggiano,s Little Italy(R) restaurants begin the sixth annual "Eat-A-Dish ... five Chicago-area Maggiano,s are taking part in the program ... the nonprofit organization that makes wishes come true for ...
... Up 191% - , , - Total Net Sales in Line ... be Held Today at 3:30 pm Central Time - ... UPI ), a medical device company that develops, manufactures and markets innovative ... fourth quarter and full year ended March 31, 2009. Net sales ...
... could mutate and become more dangerous as it travels from ... In what would seem to be some encouraging news in ... official said Thursday that samples of the virus from points ... in the United States. , "We have tested isolates from ...
Cached Medicine News:Health News:Career Step Partners with Piedmont Community College to Help Students Gain Careers in Growing Healthcare Industry 2Health News:Angelica Corporation Raises Bar Again for Increased Patient Safety 2Health News:Univision's Doctora Aliza Launches VidaySalud.com(TM) 2Health News:Maggiano's Little Italy(R) Celebrates Sixth Annual 'Eat-A-Dish for Make-A-Wish(R)' in Chicago 2Health News:Maggiano's Little Italy(R) Celebrates Sixth Annual 'Eat-A-Dish for Make-A-Wish(R)' in Chicago 3Health News:Maggiano's Little Italy(R) Celebrates Sixth Annual 'Eat-A-Dish for Make-A-Wish(R)' in Chicago 4Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 2Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 3Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 4Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 5Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 6Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 7Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 8Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 9Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 10Health News:Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 11Health News:Global Testing Shows No Variation in Swine Flu Virus 2Health News:Global Testing Shows No Variation in Swine Flu Virus 3Health News:Global Testing Shows No Variation in Swine Flu Virus 4Health News:Global Testing Shows No Variation in Swine Flu Virus 5Health News:Global Testing Shows No Variation in Swine Flu Virus 6Health News:Global Testing Shows No Variation in Swine Flu Virus 7Health News:Global Testing Shows No Variation in Swine Flu Virus 8Health News:Global Testing Shows No Variation in Swine Flu Virus 9Health News:Global Testing Shows No Variation in Swine Flu Virus 10Health News:Global Testing Shows No Variation in Swine Flu Virus 11
Designed to meet the requirements of reagent grade water for routine analysis....
... L/min of Type I ultrapure water, , ... Plus System is designed to provide the ... pretreated by reverse osmosis, distillation or deionization. ... quality which exceeds Type I ASTM/CAP/NCCLS specifications.,The ...
... Basic Laboratory Needs, Synergy systems produce ultrapure water ... 1 to 1.2 L/min to meet the basic ... incorporates a dual-wavelength UV lamp (185 nm and ... of organic contaminants (< 5 ppb TOC when ...
... Compact System Produces Type I Water Directly from ... designed for scientists who need 5 to 15 ... not have easy access to acceptable quality pretreated ... 0.6 L/min of ultrapure (Type I) water on ...
Medicine Products: